Market Research Reports and Industry Reports

Regenerative Medicine Market by technology (Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecules & Biologics), Material (Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Material, Collagen, Xenogeneic Material, Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells Three-Dimensional Polymer Technology, Transgenic, Fibroblasts, Neural Stem Cells Gene-Activated Matrices, Small Molecules, and Biologics) and Application (Cardiov

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Regenerative medicines hold the ability to replace, repair, and regenerate tissues and organs that are affected due to some disease, injury, or natural ageing process. These medicines are capable of restoring the functionality of tissues & cells applicable in a wide range of degenerative disorders such as neurodegenerative diseases, dermatology, cardiovascular and orthopedic applications. Researchers have been focusing on the development of advanced technologies based on genes, biologics, somatic cells and stem cells. Stem cells have the capability to proliferate and differentiate owing to which they are of importance in this field. Currently, predominant treatments available for degenerative or life-threatening diseases do not provide a treatment or are palliative; however, regenerative medicines have the ability to replace or regenerate the tissues and organs suffering from injury or disease. Moreover, the exploitation of nano-materials in drug delivery, wound care and immunomodulation are opportunistic for the regenerative medicine market.

The growth of this market is attributed by the factors such as an emergence of stem cell technology, valuable potential of nanotechnology, rising prevalence of chronic diseases & trauma emergencies, innovation in monitoring devices and surgical technologies. Moreover, rising incidence of degenerative diseases specifically and shortage for organ transplants has boosted the market growth. Furthermore, the increasing focus on stem cells with new source, and getting core competency in the emerging economies are expected to supplement the growth in future. The developing nations are adopting technological advanced treatment modalities at a rapid pace, which is expected to assist in the market expansion worldwide. However, operational inefficiency, stringent regulations, and the high cost of the treatment through regenerative medicine deters the market progression.

The report segments the world regenerative medicine market based on product type, material, application, and geography. Based on product type, it is categorized into cell therapy, gene therapy, tissue engineering, and small molecules & biologics. Cell therapy dominated the market among all other products owing to its efficiency to restore the lost function of any tissue or organ. However, the small molecules & biologics segment is anticipated to grow at a highest CAGR of 34.2% from 2016 to 2022, due to its potential to stimulate dormant or endogenous cells to regain their regenerative properties.

Based on material, the market is classified into synthetic materials, biologically derived materials, genetically engineered materials, and pharmaceuticals. The world regenerative medicine market is expected to reach $30,237 million by 2022 at a CAGR of 33.1% during 2016-2022. These materials are further subcategorized into different segments. The biologically derived materials accounted for about 4/7th of total market share in 2015, and is estimated to retain its position during the analysis period. The increasing demand for genetically engineered materials specially due to their unique properties such as promotion of increased proliferation, cellular interactions, and differentiation of cells that facilitates self-assembly into organized structures, and controlling the manipulation of cellular behavior.

On the basis of application, Regenerative medicine market is segmented as cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. The musculoskeletal application accounted for the largest share in 2015, whereas cardiovascular is expected to be the fastest growing segment at a CAGR of 35.3% during the analysis period.

Geographically, the market is divided into North America, Europe, Asia-Pacific, and LAMEA regions. North America is projected to dominate the overall market owing to the rising incidence of chronic disorders, growing demand for artificial organs due to the rise in the cases of organ failure, and presence of highly sophisticated healthcare infrastructure. Asia-Pacific is projected to emerge as the region with maximum growth potential, with a CAGR of 39.9% during the forecast period, due to the presence of high unmet medical needs and persistently improving healthcare infrastructure. In addition, chief countries such as India, China, Australia and Japan contribute to the market growth due to high population base, rising demand for tissue-engineered and regenerative medicine products. These countries have varying demographic and cultural conditions, which highly influence their respective markets.

Key players operating in the regenerative medicine market include Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Baxter International Inc., DePuy Synthes, Organogenesis Inc. (Advanced Biohealing), Integra Lifesciences Holdings Corporation, Acelity Holdings, Inc., Ocata Therapeutics Inc. (Astellas Pharma Inc.), and CryoLife Inc.

KEY BENEFITS
The report includes an extensive analysis of the factors driving as well as restraining the world regenerative medicine market.
The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis from 2014 to 2022 that is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis by product, material, application, and geography helps in understanding the various types of devices used for different chronic abnormalities.
Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.

Key Market Segments:
BY TECHNOLOGY
o Cell Therapy
o Gene Therapy
o Tissue Engineering
o Small Molecules & Biologics
BY MATERIAL
o Synthetic Materials
Biodegradable Synthetic Polymers
Scaffold
Artificial Vascular Graft Materials
Hydrogel Material
o Biologically Derived Materials
Collagen
Xenogeneic Material
o Genetically Engineered Materials
Deoxyribonucleic Acid Transfection Vectors
Genetically Manipulated Cells
Three-Dimensional Polymer Technology
Transgenic
Fibroblasts
Neural Stem Cells
Gene-Activated Matrices
o Pharmaceuticals
Small Molecules
Biologics
BY APPLICATION
o Cardiovascular
o Oncology
o Dermatology
o Musculoskeletal
o Wound Healing
o Ophthalmology
o Neurology
o Others
BY GEOGRAPHY
o North America
U.S.
Canada
Mexico
o Europe
Germany
UK
France
Italy
Spain
Russia
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Taiwan
Rest of Asia-Pacific
o LAMEA
Brazil
Turkey
Venezuela
Saudi Arabia
Republic of South Africa
Rest of LAMEA
Chapter: 1 INTRODUCTION
1.1 Report description
1.2 KEY BENEFITS
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models


$0(SU)
Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO perspective


$171(SU)
Chapter: 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threat of new entrants
3.3.4 Competitive rivalry
3.3.5 Treat of substitutes

3.4 Market dynamics

3.4.1 Drivers

3.4.1.1 High adoption of Stem cell technology
3.4.1.2 Emerging application of nanotechnology
3.4.1.3 Increasing prevalence of chronic diseases and trauma emergencies
3.4.1.4 Advancements in Medical Equipment technologies

3.4.2 Restraints

3.4.2.1 Complex regeneration processes
3.4.2.2 Costly treatment Associated with regenerative medicne

3.4.3 Opportunities

3.4.3.1 Lucrative opportunities of novel stem cell technologies
3.4.3.2 Increasing potential in emerging economies
3.4.3.3 Growing need of regenerative medicine in organ transplantation


$398(SU)
Chapter: 4 WORLD REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022
4.1 Overview

4.1.1 Market size and forecast

4.2 Cell therapy

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Gene therapy

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Tissue Engineering

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

4.5 Small molecules and biologics

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast


$1251(SU)
Chapter: 5 WORLD REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2015-2022
5.1 Overview

5.1.1 Market size and forecast

5.2 Synthetic materials

5.2.1 Market size and forecast
5.2.2 Biodegradable synthetic polymers

5.2.2.1 Market size and forecast

5.2.3 Scaffold

5.2.3.1 Market size and forecast

5.2.4 Artificial vascular graft materials

5.2.4.1 Market size and forecast

5.2.5 Hydrogel material

5.2.5.1 Market size and forecast

5.3 Biologically derived materials

5.3.1 Market size and forecast
5.3.2 Collagen

5.3.2.1 Market size and forecast

5.3.3 Xenogeneic material

5.3.3.1 Market size and forecast

5.4 Genetically Engineered Materials

5.4.1 Market size and forecast
5.4.2 Deoxyribonucleic Acid Transfection Vectors

5.4.2.1 Market size and forecast

5.4.3 Genetically manipulated cells

5.4.3.1 Market size and forecast

5.4.4 Three-dimensional polymer technology

5.4.4.1 Market size and forecast

5.4.5 Transgenic

5.4.5.1 Market size and forecast

5.4.6 Fibroblasts

5.4.6.1 Market size and forecast

5.4.7 Neural stem cells

5.4.7.1 Market size and forecast

5.4.8 Gene-activated matrices

5.4.8.1 Market size and forecast

5.5 Pharmaceuticals

5.5.1 Market size and forecast
5.5.2 Small molecules

5.5.2.1 Market size and forecast

5.5.3 Biologics

5.5.3.1 Market size and forecast


$1422(SU)
Chapter: 6 WORLD REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2015-2022
6.1 Overview

6.1.1 Market size and forecast

6.2 Cardiovascular

6.2.1 Market size and forecast

6.3 Oncology

6.3.1 Market size and forecast

6.4 Dermatology

6.4.1 Market size and forecast

6.5 Musculoskeletal

6.5.1 Market size and forecast

6.6 Wound healing

6.6.1 Market size and forecast

6.7 Ophthalmology

6.7.1 Market size and forecast

6.8 Neurology

6.8.1 Market size and forecast

6.9 Other

6.9.1 Market size and forecast


$910(SU)
Chapter: 7 WORLD REGENERATIVE MEDICINE MARKET, BY GEOGRAPHY, 2015-2022
7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.2.4 U.S.

7.2.4.1 Market size and forecast

7.2.5 Canada

7.2.5.1 Market size and forecast

7.2.6 Mexico

7.2.6.1 Market size and forecast

7.3 Europe

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.3.4 Germany

7.3.4.1 Market size and forecast

7.3.5 France

7.3.5.1 Market size and forecast

7.3.6 U.K.

7.3.6.1 Market size and forecast

7.3.7 Italy

7.3.7.1 Market size and forecast

7.3.8 Spain

7.3.8.1 Market size and forecast

7.3.9 Russia

7.3.9.1 Market size and forecast

7.3.10 Rest of Europe

7.3.10.1 Market size and forecast

7.4 Asia-Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.4.4 Japan

7.4.4.1 Market size and forecast

7.4.5 China

7.4.5.1 Market size and forecast

7.4.6 Australia

7.4.6.1 Market size and forecast

7.4.7 India

7.4.7.1 Market size and forecast

7.4.8 South Korea

7.4.8.1 Market size and forecast

7.4.9 Taiwan

7.4.9.1 Market size and forecast

7.4.10 Rest of Asia-Pacific

7.4.10.1 Market size and forecast

7.5 LAMEA

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
7.5.4 Brazil

7.5.4.1 Market size and forecast

7.5.5 Turkey

7.5.5.1 Market size and forecast

7.5.6 Venezuela

7.5.6.1 Market size and forecast

7.5.7 Saudi Arabia

7.5.7.1 Market size and forecast

7.5.8 Republic of South Africa

7.5.8.1 Market size and forecast

7.5.9 Others LAMEA

7.5.9.1 Market size and forecast


$1081(SU)
Chapter: 8 COMPANY PROFILES
8.1 Integra Lifesciences Corporation

8.1.1 Company overview
8.1.2 Operating business segments
8.1.3 Business performance
8.1.4 Key strategic moves and developments

8.2 Stryker Corporation

8.2.1 Company overview
8.2.2 Operating business segments
8.2.3 Business performance
8.2.4 Key strategic moves and developments

8.3 Acelity Holdings, Inc. (LifeCell Corporation)

8.3.1 Company overview
8.3.2 Operating business segments
8.3.3 Business performance
8.3.4 Key strategic moves and developments

8.4 Organogenesis Inc. (Advanced Biohealing)

8.4.1 Company overview
8.4.2 Operating business segments
8.4.3 Key strategic moves and developments

8.5 Arteriocyte Medical Systems, Inc.

8.5.1 Company overview
8.5.2 Operating business segments
8.5.3 Key strategic moves and developments

8.6 Athersys, Inc.

8.6.1 Company overview
8.6.2 Operating business segments
8.6.3 Business performance
8.6.4 Key strategic moves and developments

8.7 U.S. Stem Cell, Inc. (Bioheart, Inc.)

8.7.1 Company overview
8.7.2 Operating business segments
8.7.3 Business performance
8.7.4 Key strategic moves and developments

8.8 Zimmer Biomet Holdings, Inc. (Zimmer)

8.8.1 Company overview
8.8.2 Operating business segments
8.8.3 Business performance
8.8.4 Key strategic moves and developments

8.9 CryoLife, Inc.

8.9.1 Company overview
8.9.2 Operating business segments
8.9.3 Business performance
8.9.4 Key strategic moves and developments

8.10 Medtronic plc

8.10.1 Company overview
8.10.2 Operating business segments
8.10.3 Business performance
8.10.4 Key strategic moves and developments

List Of Tables



TABLE 1 UNINTENTIONAL INJURIES FACTS (2013)
TABLE 2 TRENDS IN REGENERATIVE MEDICINE INDUSTRY (2007-2011)
TABLE 3 WORLD REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 4 WORLD REGENERATIVE MEDICINE MARKET FOR CELL THERAPY, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 5 WORLD REGENERATIVE MEDICINE MARKET FOR GENE THERAPY, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 6 WORLD REGENERATIVE MEDICINE MARKET FOR TISSUE ENGINEERING, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 7 WORLD REGENERATIVE MEDICINE MARKET FOR SMALL MOLECULES AND BIOLOGICS, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 8 WORLD REGENERATIVE MEDICINE MARKET, BY MATERIAL, 2015-2022 ($MILLION)
TABLE 9 WORLD REGENRATIVE MEDICINE MARKET FOR SYNTHETIC MATERIALS, 2015-2022 ($MILLION)
TABLE 10 WORLD SYNTHETIC MATERIAL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 11 CLASSIFICATION OF BIODEGRADABLE POLYMERS
TABLE 12 WORLD BIODEGRADABLE SYNTHETIC POLYMERS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 13 LIST OF COMMERCIAL POLYMERIC SCAFFOLDS PRODUCTS
TABLE 14 WORLD SCAFFOLD MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 15 WORLD ARTIFICIAL VASCULAR GRAFT MATERIALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 16 WORLD HYDROGEL MATERIAL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 17 WORLD REGENERATIVE MEDICINE MARKET FOR BIOLOGICALLY DERIVED MATERIALS, 2015-2022 ($MILLION)
TABLE 18 WORLD BIOLOGICALLY DERIVED MATERIALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 19 WORLD COLLAGEN MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 20 WORLD XENOGENEIC MATERIAL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 21 WORLD REGENERATIVE MEDICINE MARKET FOR GENETICALLY ENGINEERED MATERIALS, 2015-2022 ($MILLION)
TABLE 22 WORLD GENETICALLY ENGINEERED MATERIALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 23 WORLD DEOXYRIBONUCLEIC ACID TRANSFECTION VECTORS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 24 WORLD GENETICALLY MANIPULATED CELLS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 25 WORLD THREE-DIMENSIONAL POLYMER TECHNOLOGY MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 26 WORLD TRANSGENIC MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 27 WORLD FIBROBLASTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 28 WORLD NEURAL STEM CELLS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 29 WORLD GENE-ACTIVATED MATRICES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 30 WORLD REGENERATIVE MEDICINE MARKET FOR PHARMACEUTICALS, 2015-2022 ($MILLION)
TABLE 31 WORLD PHARMACEUTICALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 32 WORLD REGENERATIVE MEDICINE MARKET, BY APPLICATION, 2015-2022 ($MILLION)
TABLE 33 WORLD CARDIOVASCULAR APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 34 WORLD ONCOLOGY APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 35 STATISTICS FOR SKIN DAMAGE MEDICAL CONDITIONS IN THE U.S. AND WORLDWIDE, 2011
TABLE 36 LIST OF ACELLULAR SKIN TISSUE-ENGINEERED PRODUCTS IN THE MARKET
TABLE 37 LIST OF CELLULAR SKIN TISSUE-ENGINEERED PRODUCTS IN THE MARKET
TABLE 38 WORLD DERMATOLOGY APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 39 STATISTICS FOR BONE DAMAGE AND RELATED DISEASES, 2011
TABLE 40 STATISTICS FOR CARTILAGE DAMAGE WORLDWIDE
TABLE 41 WORLD MUSCULOSKELETAL APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 42 WORLD WOUND HEALING APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 43 WORLD OPHTHALMOLOGY APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 44 WORLD NEUROLOGY APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 45 WORLD OTHER APPLICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 46 WORLD REGENERATIVE MEDICINE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 47 NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 48 NORTH AMERICA REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 49 EUROPEAN REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 50 EUROPEAN REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 51 ASIAPACIFIC REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 52 ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 53 LAMEA REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 54 LAMEA REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2015-2022 ($MILLION)
TABLE 55 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 56 INTEGRA LIFESCIENCES: OPERATING SEGMENTS
TABLE 57 STRYKER: COMPANY SNAPSHOT
TABLE 58 STRYKER: OPERATING SEGMENTS
TABLE 59 ACELITY: COMPANY SNAPSHOT
TABLE 60 ACELITY: OPERATING SEGMENTS
TABLE 61 ORGANOGENESIS: COMPANY SNAPSHOT
TABLE 62 ORGANOGENESIS, INC.: PRODUCT SEGMENT
TABLE 63 ARTERIOCYTE: COMPANY SNAPSHOT
TABLE 64 ARTERIOCYTE: OPERATING SEGMENT
TABLE 65 ATHERSYS: COMPANY SNAPSHOT
TABLE 66 ATHERSYS: OPERATING SEGMENTS
TABLE 67 US STEM CELL: COMPANY SNAPSHOT
TABLE 68 ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 69 ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 70 CRYOLIFE: COMPANY SNAPSHOT
TABLE 71 CRYOLIFE: OPERATING SEGMENTS
TABLE 72 MEDTRONIC: COMPANY SNAPSHOT
TABLE 73 MEDTRONIC: OPERATING SEGMENTS

List Of Figures



FIG. 1 TOP INVESTMENT POCKETS IN WORLD REGENERATIVE MEDICINE MARKET
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIG. 3 PORTERS FIVE FORCES ANALYSIS
FIG. 4 TOP IMPACTING FACTORS: WORLD REGENERATIVE MEDICINE MARKET
FIG. 5 GROWTH IN DISEASE TREATED VS. CLINICAL TRIALS (2008-2012)
FIG. 6 WORLD REGENERATIVE MEDICINE MARKET FOR SMALL MOLECULES, 2015-2022 ($MILLION)
FIG. 7 WORLD REGENERATIVE MEDICINE MARKET FOR BIOLOGICS, 2015-2022 ($MILLION)
FIG. 8 U.S. REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 9 CANADA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 10 MEXICO REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 11 GERMANY REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 12 FRANCE REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 13 UK REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 14 ITALY REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 15 SPAIN REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 16 RUSSIAN REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 17 REST OF EUROPE REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 18 JAPAN REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 19 CHINA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 20 AUSTRALIA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 21 INDIAN REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 22 SOUTH KOREA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION
FIG. 23 TAIWAN REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 24 REST OF ASIA-PACIFIC REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 25 BRAZIL REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 26 TURKEY REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 27 VENEZUELA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 28 SAUDI ARABIA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 29 REPUBLIC OF SOUTH AFRICA REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 30 OTHER REGENERATIVE MEDICINE MARKET, 2015-2022 ($MILLION)
FIG. 31 INTEGRA LIFESCIENCES: REVENUE, 2013-2015 ($MILLION)
FIG. 32 INTEGRA LIFESCIENCES: REVENUE, BY SEGMENT, 2015 (%)
FIG. 33 INTEGRA LIFESCIENCES: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 34 STRYKER CORPORATION: REVENUE, 2013-2015 ($MILLION)
FIG. 35 STRYKER CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
FIG. 36 STRYKER CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 37 ACELITY: REVENUE, 2013-2015 ($MILLION)
FIG. 38 ACELITY: REVENUE, BY SEGMENT, 2015 (%)
FIG. 39 ACELITY: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 40 ATHERSYS: REVENUE, 2013-2015 ($MILLION)
FIG. 41 US STEM CELL: REVENUE, 2013-2015 ($MILLION)
FIG. 42 ZIMMER BIOMET: REVENUE, 2013-2015 ($MILLION)
FIG. 43 ZIMMER BIOMET: REVENUE, BY SEGMENT, 2015 (%)
FIG. 44 ZIMMER BIOMET: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 45 CRYOLIFE: REVENUE, 2013-2015 ($MILLION)
FIG. 47 CRYOLIFE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 48 MEDTRONIC: REVENUE, 2013-2015 ($MILLION)
FIG. 49 MEDTRONIC: REVENUE, BY SEGMENT, 2015 (%)
FIG. 50 MEDTRONIC: REVENUE, BY GEOGRAPHY, 2015 (%)

Shire Regenerative Medicine, Inc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Shire Regenerative Medicine, Inc Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

California Institute for Regenerative Medicine Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

California Institute for Regenerative Medicine Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions,

USD 200View Report

United States Bone Substitute for Regenerative Dentistry Market Report 2016

Notes:Sales, means the sales volume of Bone Substitute for Regenerative DentistryRevenue, means the sales value of Bone Substitute for Regenerative DentistryThis report studies sales (consumption) of Bone Substitute for Regenerative

USD 3800View Report

United States Pulmonary Arterial Hypertension (PAH) Medicine Market Report 2016

Notes:Sales, means the sales volume of Pulmonary Arterial Hypertension (PAH) MedicineRevenue, means the sales value of Pulmonary Arterial Hypertension (PAH) MedicineThis report studies sales (consumption) of Pulmonary Arterial Hypertension (PAH)

USD 3800View Report

China Bioelectric Medicine Market Research Report 2016

Notes:Sales, means the sales volume of Bioelectric MedicineRevenue, means the sales value of Bioelectric MedicineThis report studies Bioelectric Medicine in China market, focuses on the top players in China market,

USD 3200View Report

Global Allergy Medicine Market Research Report 2016

Notes:Production, means the output of Allergy MedicineRevenue, means the sales value of Allergy MedicineThis report studies Allergy Medicine in Global market, especially in North America, Europe, China, Japan, Southeast Asia

USD 2900View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 4740
  • Five User Licence    $ 5910
  • Enterprise Wide Licence    $ 8250
  • DataPack    $ 3840
$ 4740

Reports Details

Published Date : Aug 2016
No. of Pages :145
Country :Global
Category :Healthcare
Publisher :Allied Market Research
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment